- PLN124.93m
- PLN143.63m
- PLN15.76m
Brief: Mabion Adopts Strategy For 2025-2030
Brief: Mabion Signs About 2 Mln Zloty Deal With WPD Pharmaceuticals
Brief: Mabion Signs Strategic Cooperation Deal With Sartorius
Brief: Mabion Sigs Framework Deal With IBMP For Clinical Supply Services
Brief: Mabion Concludes Annex To Deal With Bonfiglioli Engineering
Brief: Mabion To Withdraw From Project And Funding Agreement
Brief: Mabion Q3 Net Loss At 16.3 Mln Zlotys
Brief: Mabion Signs Framework Deal With UK Pharmaceutical Company
Brief: Mabion To Get 6.4 Mln Zloty Subsidy For Project
Brief: Mabion Q2 Net Profit At 10.3 Mln Zlotys
Brief: Mabion Signs Statement Of Work With UK-Based Company
Brief: Mabion Expands Collaboration With Novavax On Flu And COVID Vaccine Research
Brief: Mabion AGM To Vote On Allocating FY 2023 Net Profit For Coverage Of Losses
Brief: Mabion Q1 Net Profit Up At 17.5 Mln Zlotys
Brief: Mabion FY Net Profit Up At 41.3 Mln Zlotys
Brief: Mabion Prelim. FY Net Profit At 41.3 Mln Zlotys
Brief: Poland's Mabion Q3 Net Result Turns To Profit Of 10.9 Mln Zlotys
Brief: Mabion And Novavax Terminates Research Cooperation On SARS CoV-2 RS Wuhan Variant
Brief: Mabion Q2 Net Profit Up At 15.2 Mln Zlotys